Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

Menstrual Cycle Could Be Contributing To Sickle Cell Pain Events By Dennis Thompson HealthDay Reporter MONDAY, April 14, 2025 (HealthDay News) -- Women with sickle cell disease often have pain ...

“The amount of inflammation is significantly elevated in the follicular phase, or first half, of the menstrual cycle in female patients with sickle cell disease,” said lead researcher Dr ...

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease Levels of C-reactive protein increase among women with sickle cell disease during the first ...

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients with sickle cell disease (SCD), according to ...

The diagram above shows a simple flash cell design. Electrons are stored in ... to mitigate the performance impact of the program/erase cycle by performing certain tasks in the background.

The landmark discovery of the BCL-2 gene and its function marked the inhibition of apoptotic cell death as a crucial mechanism driving cancer development. This new review brings together some of ...

Ki-67 and cell cycle regulator proteins are highly expressed in many cancers and linked to prognosis. This study aims to investigate their differential expression in LUAD with different radiological ...